Ornidazole‐induced liver damage: report of three cases and review of the literature
Authors:
- 22 September 2003
- journal article
- case report
- Published by Wiley in Liver International
- Vol. 23 (5) , 351-354
Abstract
Metronidazole and ornidazole, synthetic nitroimidazole derivatives, are used in the treatment of infections caused by anaerobic bacteria and protozoa. The drugs are well tolerated and serious side effects are very rarely encountered. Hepatotoxicity is a rare side effect and hitherto only six cases have been reported. We describe three patients who developed hepatitis after ornidazole use and review the previously reported cases. All three cases used ornidazole in conventional doses and developed hepatitis and associated cholestasis. They improved 1–2 months after discontinuation. We concluded that nitroimidazole derivatives may cause hepatotoxic damage resembling acute cholestatic hepatitis. Early recognition and withdrawal of the drug may prevent further damage.Keywords
This publication has 12 references indexed in Scilit:
- Nitroimidazole-induced chronic hepatitisEuropean Journal of Gastroenterology & Hepatology, 2001
- Ornidazole-induced autoimmune hepatitisEuropean Journal of Gastroenterology & Hepatology, 2001
- Drug-induced liver diseaseCurrent Opinion in Gastroenterology, 2001
- DRUG-INDUCED LIVER DISEASEClinics in Liver Disease, 2000
- A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugsBritish Journal of Clinical Pharmacology, 1999
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 1995
- Metronidazole-Associated Hepatotoxicity in a Hemodialyzed PatientNephron, 1994
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990
- MetronidazoleNew England Journal of Medicine, 1980
- Fate of Cardiology Research Originally Published in Abstract Form | NEJMNew England Journal of Medicine, 1980